We could not find any results for:
Make sure your spelling is correct or try broadening your search.
N 5 April 2017 Further to LivaNova Plc's ("LivaNova") announcement on 23 February 2017 that it had made an application (i) to the UK Financial Conduct Authority for the cancellation...
N 3 April 2017 Total Voting Rights and Share Capital In accordance with Disclosure and Transparency Rule 5.6, LivaNova PLC (the "Company") hereby notifies the market that as of 31 March...
LivaNova PLC Reiterates Full-Year 2017 Guidance PR Newswire LONDON, April 1, 2017 LONDON, April 1, 2017 /PRNewswire/ -- LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) ("LivaNova" or the "Company"), a...
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced it is reiterating its full-year 2017 guidance...
News) - Medical technology business LivaNova PLC on Friday said Vivid Sehgal is resigning as chief financial officer, ...
N RNS - LivaNova Plc: Resignation of Chief Financial Officer THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. 31 March 2017 LivaNova Plc - Resignation of Chief Financial Officer On 29 March 2017...
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced its Chief Financial Officer, Vivid Sehgal, is...
N 1. Identity of the issuer Livanova Plc or the underlying issuer of existing shares to which voting rights are attached:ii 2 Reason for the notification(please tick the appropriate box or...
N LivaNova to Host Conference Call for First Quarter 2017 Results London, 29 March 2017 - LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) ("LivaNova" or the "Company"), a market-leading...
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, will host a conference call to discuss its first quarter results on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions